autoimmune drugs

Autoimmune drug pipeline highlightsMore targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
Will new biosimilars hurt blockbuster autoimmune drug?
Will new biosimilars hurt blockbuster autoimmune drug?New biosimilars may harm the sales of this autoimmune blockbuster.
Autoimmune Drug Market Could Take OffWhy the market is expecting such significant growth (and how pharmacists can keep their patients in the huge market).